[Assessment of various prognostic factors in patients irradiated for bone metastases].
Prognostic survival rate is one of the factors decisive about the kind of the local therapy at patients with bone metastases. The work evaluates chosen prognostic parameters such as age, sex, the presence of extra-skeletal metastases, the existence of pathological fracture and the applications of bisphosphonates and/or systemic treatment at 305 patients irradiated due to bone metastases. The median survival rate was 6.2 months and was significantly depended from primary location of the disease. The sex, age and number of metastatic foci had no significant influence on the median survival rate however the remaining prognostic factors depended on the primary location of the neoplasm.
Mazurkiewicz
Maria
M
Katedra i Zakład Onkologii, Akademii Medycznej w Lublinie.
Brzozowska
Anna
A
Mazurkiewicz
Tomasz
T
Grzybowska-Szatkowska
Ludmiła
L
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D001859:Bone Neoplasms / Q000188:drug therapy / Q000532:radiotherapy* / Q000556:secondary*; D004164:Diphosphonates / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D012737:Sex Factors; D016019:Survival Analysis
D004164:Diphosphonates